Venture
RS BioTherapeutics Inc.
Latest Form D 2024-10-09- CIK 1932193
- State MD
- Other Health Care
- 4 Form D offerings since 2022-06-21
- Total sold
- $1.9M
- across 4 offerings
- Rounds
- 4
- Form D offerings since 2022-06-21
- Latest round
- $20K
- 2024-10-09 · 021-526303
- Investors
- 1
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2024-10-09 · $20K
- 2022-06-21$685K021-449739
- 2023-03-22$100K021-476630
- 2023-08-10$1.1M021-489382
- 2024-10-09$20K021-526303
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($1.1M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-526303 | First filed2024-10-09 | Latest2024-10-09 | Sought$2M | Sold$20K | Investors1 | Exemptions506(b) |
| 021-489382 | First filed2023-08-10 | Latest2023-10-19 | Sought$5M | Sold$1.1M | Investors5 | Exemptions506(b) |
| 021-476630 | First filed2023-03-22 | Latest2023-03-22 | Sought$10M | Sold$100K | Investors1 | Exemptions506(b) |
| 021-449739 | First filed2022-06-21 | Latest2022-06-21 | Sought$4M | Sold$685K | Investors6 | Exemptions506(b) |
Who backs RS BioTherapeutics Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2024-10-09
| Name | Relationship |
|---|---|
| Curtis Rhine | RelationshipExecutive Officer |
| H. Dean Hart | RelationshipExecutive Officer |
| David Freas | RelationshipDirector |
| Justin Molignoni | RelationshipExecutive Officer, Director |
| Michael Guzman | RelationshipExecutive Officer |
Facts
As its latest Form D states them
- Industry
- Other Health Care
- State
- Maryland (MD)
- Exemptions
- Rule 506(b)
- First filed
- 2022-06-21
- Latest filing
- 2024-10-09
Who backs RS BioTherapeutics Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plans
External link: SEC Filings ↗